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1. Introduction 
Plasma fibronectin is a glycoprotein which consists 
of 2 disulphide-bridged polypeptide chains ofM r 
215 000 and 220 000, respectively [ 1,2], whereas 
fibronectin associated with the cell surface is found 
both as a dimer and as a multimer [3]. Fibronectin 
forms strong non-covalent bonds with collagen [4] 
and heparin [5]. It interacts with cell surfaces [6] 
and has been reported to bind some other macro- 
molecules including actin [7] and fibrin [8]. Fibro- 
nectin can be covalently crosslinked by plasma trans- 
glutaminase (factor Xllla) [9] to fibrin [10], collagen 
[11 ], Staphylococcus aureus cells [12] and to itself 
[ 13 ]. Cellular fibronectin agglutinates sheep erythro- 
cytes [14] and restores normal fibroblastic morphol- 
ogy to transformed cells [ 14]. Plasma fibronectin is
necessary for opsonization of gelatin-coated particles 
[15]. 
Degradation of fibronectin with chemicals or pro- 
teolytic enzymes has revealed a domain structure 
(reviewed in [ 16]) with different domains taking part 
in crosslinking by factor XIII a [ 10,17,18], binding to 
cells [19], collagen [20] and heparin [19,21 ]. Fibro- 
nectin contains 1-2 thiol groups/monomer [ 16,22-25], 
and blockage of the free sulfhydryl group prevents 
binding to cells [22]. Cleavage by S-cyanylation [25] 
suggests acysteine located 170 000 mass units from 
the N-terminus. 
After digestion of bovine fibronectin with plasmin, 
4 fragments ofM r 29 000 (29k), 170 000 (170k), 
23 000 (23k) and 6000 (6k) have been isolated [26] 
and here we report he amino acid sequence of a 
stretch of 27 amino acid residues of bovine fibronectin 
* Present address: Sir Dunn School of Chemical Pathology, 
South Park Road, Oxford OX1 3RE, England 
containing a cysteine, labelled by treatment of dena- 
tured 170k with laC-labelled iodoacetic acid. 
2. Experimental 
Bovine plasma fibronectin was purified essentially 
as described for the human protein [4] by batch 
adsorption to gelatin-agarose followed by elution 
with a gradient of urea. The fractions containing fibro- 
nectin were pooled and dialysed against demineralised 
water, and 0.05 M NH4HCOa before digestion with 
plasmin. Human plasminogen was purified as in [27] 
and activated with streptokinase (Kabi). Elastase was 
a gift from D. Shotton. Peptides were sequenced on a 
Beckman 890 sequencer, using polyprene [28] and 
the phenyhsothiocyanate derivatives were identified 
by high-performance liquid chromatography [29]. 
For all other experimental methods, see [30]. 
Fibronectin (4 g) was digested with 40 mg activated 
plasminogen and the fragments obtained were purified 
on columns of DEAE-cellulose and gelatin-agarose as 
in [ 17]. The effluent was monitored for thiol groups 
by reacting aliquots (0.2-0.6 ml) with 5,5'-dithiobis- 
(2-nitrobenzoic) acid (DTNB) tPmka) in the presence 
or absence of 6 M guanidine-HC1 [31 ]. The fractions 
showing positive reaction were collected in one pool, 
dialysed against demineralised water, lyophilised and 
redissolved in 50 ml 6 M guanidine-HC1, 0.2 M Tris, 
0.01 M EDTA (pH 8.3). The solution was incubated 
with 150 #Ci 2-[14C]iodoacetic a id (54 Ci/mol, 
Amersham) for 1 h and then with a surplus of unla- 
belled sodium iodoacetate. The reaction mixture was 
dialyzed against running tap water, followed by 
demineralized water and after lyophilisation, reduced 
and alkylated with unlabelled sodium iodoacetate as
in [30]. Following resalting on Sephadex G-25 in 
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0.1 M NH4HCO3 the protein solution was incubated 
with 76 mg trypsin (Worthington) for 20 h at 37°C. 
The digestion was stopped by adding soybean trypsin 
inhibitor. The digestion mixture was fractionated on 
a column of Sephacryl S-200 in 0.1 M NH4HCO3 
(pH 8.3). The radioactive fractions were collected in 
one pool and further separated on a column of DEAE- 
Sephacel (1 × 25 cm) in a linear gradient from 
0.1-0.5 M NH4HCO3 (2 × 250 ml). 
3. Results 
Of the 4 main fragments 29k, 170k, 23k and 6k, 
obtained by digestion of bovine plasma fibronectin 
with plasmin [26] only 170k showed a positive reac- 
tion with DTNB. After labelling of this fragment with 
radioactive iodoacetic acid under denaturing condi- 
tions, the fragment was reduced, alkylated and digested 
with trypsin. The obtained peptides were fractionated 
by gel filtration and ion-exchange chromatography 
and the eluted radioactivity was found in one peak, 
called TI: A sample of T1 was further digested with 
chymotrypsin and the peptides were purified by high- 
voltage paper electrophoresis and paper chromatog- 
raphy. Only one radioactive peptide was found, cor- 
responding to T1C1 in fig.1. When T1C1 was 
sequenced, a radioactive carboxymethylcysteine was 
identified in position 13. In order to obtain more 
sequence information on the C-terminal site of the 
cysteine another sample of T1 was digested with elas- 
tase and after high-voltage paper electrophoresis at 
pH 6.5 and 1.9 a radioactive peptide was isolated, 
corresponding to T1E1 in fig.1. In the sequence of 
T 1E 1 a clear radioactive carboxymethylcysteine was 
identified in step two, corresponding to position 13 
on fig.1. The sequences of T1C1 and T1E1 are in 
accordance with their amino acid compositions. 
The peptide T1E1 was neutral at pH 1.9 and the 
amino acid analysis howed that it contained glucos- 
amine after hydrolysis. To localize the attachment 
site for the oligosaccharide group a sample of T 1 E1 
was digested with the S. aureus protease and the pep- 
tides T1E1Spl, T1E1Sp2 and T1E1Sp3 were isolated 
by high-voltage paper electrophoresis and analysed. 
They were identified by amino acid composition and 
electrophoretic mobility. Only T1E1Sp3 was found 
to contain glucosamine after hydrolysis. Sequence 
determination f T1 E 1 Sp3 by the dansyl-Edman 
technique identified an Asx-residue in step two, cor- 
responding to the Asn-25 in fig.1. As the peptide con- 
tains only one Asx, this residue must be the attach- 
ment site for the carbohydrate. When sequencing 
T1 E1 no phenylisothiocyanate derivative was identi- 
fied in the corresponding position. Although Asn-17 
is in an Asn-X-Ser sequence, no evidence was found 
for carbohydrate in this position. 
Another sample of T1E1 was digested with chymo- 
trypsin and the amino acid compositions and electro- 
phoretic mobilities of the purified peptides (T 1 E 1C 1 - 
C3) further confirmed the sequence of T1 El. 
4. Discussion 
Three different types (I-I I I) of internal homology 
have been found in bovine fibronectin [32] and 
from the sequence of 3 CNBr fragments absent in 
half-cysteines and carbohydrate, 3 domains of homol- 
ogy type III have been identified (P. S., unpublished). 
Parts of these domains are shown in fig.2 aligned with 
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Fig.1. The sequence of a cysteine containing region of bovine plasma fibronectin; CHO, carbohydrate. The peptides were obtained 
by digestion with trypsin (T), chymotrypsin (C), elastase (E) or S. aureus protease (Sp). 
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Fig.2. Alignment of sequences from bovine fibronectin (homology type HI): (1) cysteine containing region (this paper); (2,3) 
sequences from a CN-Br-fragment of 170k [32]; (4) a CNBr-fragment of 170k, which has also been found in a heparin binding frag- 
ment [ 32]; CHO, carbohydrate; ~, radioactive earboxymethylcysteine. 
the sequence from f ig. l ,  clearly showing that this 
cysteine containing sequence originates from a homol- 
ogy type III domain. Whether there is one or more 
cysteine residues/chain i  bovine plasma fibronectin 
cannot be answered from the present experiments, 
but no indications for more than the cysteine shown 
in fig. 1 have been obtained. 
The proximity between the cysteine and a site 
with carbohydrate and a potential site without carbo- 
hydrate (Asn-Leu-Ser ,  residues 17-19) ,  are similar 
to the situation in the human complement factor B. 
In this protein a site with carbohydrate has been found 
1O residues before a cysteine and an Asn-Leu-Thr  
sequence without carbohydrate 3 residues after the 
cysteine [33]. Whether this is a coincidence remains 
to be seen. 
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